BCL2 and HIV-1 infection: Treatment with IDB did not change the expression of antiapoptotic Bcl-2, but increased the expression of antiapoptotic Bcl-xL and Mcl-1 in CD4+ T cells with or without HIV-1 infections (Fig. 2a).